Effects of lack of microRNA-34 on the neural circuitry underlying the stress response and anxiety Journal Article


Authors: Andolina, D.; Di Segni, M.; Bisicchia, E.; D'Alessandro, F.; Cestari, V.; Ventura, A.; Concepcion, C.; Puglisi-Allegra, S.; Ventura, R.
Article Title: Effects of lack of microRNA-34 on the neural circuitry underlying the stress response and anxiety
Abstract: Stress-related psychiatric disorders, including anxiety, are complex diseases that have genetic, and environmental causes. Stressful experiences increase the release of prefrontal amygdala neurotransmitters, a response that is relevant to cognitive, emotional, and behavioral coping. Moreover, exposure to stress elicits anxiety-like behavior and dendritic remodeling in the amygdala. Members of the miR-34 family have been suggested to regulate synaptic plasticity and neurotransmission processes, which mediate stress-related disorders. Using mice that harbored targeted deletions of all 3 members of the miR-34-family (miR-34-TKO), we evaluated acute stress-induced basolateral amygdala (BLA)-GABAergic and medial prefrontal cortex (mpFC) aminergic outflow by intracerebral in vivo microdialysis. Moreover, we also examined fear conditioning/extinction, stress-induced anxiety, and dendritic remodeling in the BLA of stress-exposed TKO mice. We found that TKO mice showed resilience to stress-induced anxiety and facilitation in fear extinction. Accordingly, no significant increase was evident in aminergic prefrontal or amygdala GABA release, and no significant acute stress-induced amygdalar dendritic remodeling was observed in TKO mice. Differential GRM7, 5-HT2C, and CRFR1 mRNA expression was noted in the mpFC and BLA between TKO and WT mice. Our data demonstrate that the miR-34 has a critical function in regulating the behavioral and neurochemical response to acute stress and in inducing stress-related amygdala neuroplasticity. © 2016 The Authors. Published by Elsevier Ltd.
Keywords: stress; anxiety; amygdala; prefrontal cortex; mir-34
Journal Title: Neuropharmacology
Volume: 107
ISSN: 0028-3908
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2016-08-01
Start Page: 305
End Page: 316
Language: English
DOI: 10.1016/j.neuropharm.2016.03.044
PROVIDER: scopus
PUBMED: 27026110
PMCID: PMC5573597
DOI/URL:
Notes: Article -- Export Date: 2 May 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrea Ventura
    56 Ventura